Welch Group LLC decreased its stake in CME Group Inc. (NASDAQ:CME) by 31.9% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 1,319 shares of the company’s stock after selling 619 shares during the period. Welch Group LLC’s holdings in CME Group were worth $128,000 at the end of the most recent reporting period.
A number of other institutional investors also recently modified their holdings of the company. Parametrica Management Ltd acquired a new stake in CME Group during the second quarter valued at about $212,000. Franklin Resources Inc. acquired a new stake in CME Group during the first quarter valued at about $222,000. Financial Architects Inc acquired a new stake in CME Group during the second quarter valued at about $234,000. EFG Asset Management Americas Corp. acquired a new stake in CME Group during the first quarter valued at about $244,000. Finally, Windward Capital Management Co. CA increased its stake in CME Group by 1.0% in the second quarter. Windward Capital Management Co. CA now owns 2,626 shares of the company’s stock valued at $256,000 after buying an additional 25 shares in the last quarter. 80.29% of the stock is owned by hedge funds and other institutional investors.
Shares of CME Group Inc. (NASDAQ:CME) traded down 0.13% during mid-day trading on Tuesday, hitting $103.93. 1,422,096 shares of the company’s stock were exchanged. The company has a market capitalization of $35.22 billion, a price-to-earnings ratio of 26.24 and a beta of 0.83. CME Group Inc. has a 52 week low of $81.87 and a 52 week high of $110.35. The firm has a 50 day moving average price of $106.84 and a 200-day moving average price of $99.23.
CME Group (NASDAQ:CME) last released its quarterly earnings results on Thursday, July 28th. The company reported $1.14 EPS for the quarter, beating the Zacks’ consensus estimate of $1.11 by $0.03. CME Group had a net margin of 38.22% and a return on equity of 6.83%. The company had revenue of $906 million for the quarter, compared to analyst estimates of $897.84 million. During the same quarter last year, the firm posted $0.95 earnings per share. The company’s quarterly revenue was up 10.5% compared to the same quarter last year. On average, equities analysts anticipate that CME Group Inc. will post $4.44 EPS for the current year.
The company also recently declared a quarterly dividend, which was paid on Monday, September 26th. Stockholders of record on Friday, September 9th were given a $0.60 dividend. This represents a $2.40 dividend on an annualized basis and a dividend yield of 2.31%. The ex-dividend date of this dividend was Wednesday, September 7th. CME Group’s dividend payout ratio is 60.61%.
Several brokerages have recently weighed in on CME. Deutsche Bank AG upped their target price on shares of CME Group from $110.00 to $111.00 and gave the company a “buy” rating in a research note on Friday, July 29th. JPMorgan Chase & Co. upped their target price on shares of CME Group from $99.00 to $106.00 and gave the company an “overweight” rating in a research note on Friday, July 29th. Barclays PLC decreased their target price on shares of CME Group from $100.00 to $99.00 and set an “equal weight” rating for the company in a research note on Friday, July 29th. Zacks Investment Research upgraded shares of CME Group from a “sell” rating to a “hold” rating in a research note on Thursday, June 30th. Finally, Keefe, Bruyette & Woods upped their target price on shares of CME Group from $99.00 to $103.00 and gave the company a “market perform” rating in a research note on Friday, July 29th. Two equities research analysts have rated the stock with a sell rating, six have given a hold rating and six have given a buy rating to the company. The stock presently has an average rating of “Hold” and an average target price of $102.89.
In other news, insider Kimberly S. Taylor sold 2,300 shares of the firm’s stock in a transaction on Thursday, September 29th. The shares were sold at an average price of $106.01, for a total value of $243,823.00. Following the sale, the insider now owns 105,558 shares in the company, valued at $11,190,203.58. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. Also, insider Bryan T. Durkin sold 14,990 shares of the firm’s stock in a transaction on Wednesday, September 28th. The stock was sold at an average price of $105.10, for a total transaction of $1,575,449.00. Following the completion of the sale, the insider now owns 66,936 shares in the company, valued at approximately $7,034,973.60. The disclosure for this sale can be found here. 0.61% of the stock is currently owned by insiders.
About CME Group
CME Group Inc is a provider of products across all major asset classes, based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals. The Company’s products include both exchange-traded and privately negotiated futures and options contracts and swaps. The Company connects buyers and sellers together through its CME Globex electronic trading platform across the globe and its open outcry trading facilities in Chicago and New York City.
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME).
Receive News & Ratings for CME Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group Inc. and related companies with MarketBeat.com's FREE daily email newsletter.